Citations

Showing 10 of 108119 citations.

Consultative Medicine — An Emerging Specialty for Patients with Perplexing Conditions
Geng, Linda N. , Verghese, Abraham, Tilburt, Jon C., Geng, Linda N. , Verghese, Abraham, Tilburt, Jon C.

Mayo Clinic

New England Journal of Medicine | December 22, 2021 | Volume: 385 | Issue: 26 | Pages: 2478-2484

10.1056/nejmms2111017 | PMID 34936744 Get It

Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona
Jehn, Megan, Pandit, Urvashi, Sabin, Susanna, Tompkins, Camila, White, Jessica, Kaleta, Erin, Dale, Ariella P., Ross, Heather M., McCullough, J. Mac, Pepin, Susan, Kenny, Katherine, Sanborn, Heidi, Heywood, Natalie, Schnall, Amy H., Lant, Timothy, Sunenshine, Rebecca, Jehn, Megan , Pandit, Urvashi, Sabin, Susanna J. , Tompkins, Camila, White, Jessica, Kaleta, Erin, Dale, Ariella P., Ross, Heather M., McCullough, J. Mac, Pepin, Susan, Kenny, Katherine, Sanborn, Heidi, Heywood, Natalie, Schnall, Amy H., Lant, Timothy, Sunenshine, Rebecca

Mayo Clinic

American Journal of Public Health | December 22, 2021 | Volume: 112 | Issue: 1 | Pages: 38-42

10.2105/ajph.2021.306568 | PMID 34936397 Get It

We conducted a community seroprevalence survey in Arizona, from September 12 to October 1, 2020, to determine the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used the seroprevalence estimate to predict SARS-CoV-2 infections in the jurisdiction by applying the adjusted seroprevalence to the county’s population. The estimated community seroprevalence of SARS-CoV-2 infections was 4.3 times greater (95% confidence interval = 2.2, 7.5) than the number of reported cases. Field surveys with representative sampling provide data that may help fill in gaps in traditional public health reporting. (Am J Public Health. 2022;112(1):38–42. https://doi.org/10.2105/AJPH.2021.306568 )
Secondary Procedures following Flexor Tendon Reconstruction
Wu, Kitty Yuechuan, Gillis, Joshua A., Moran, Steven L., Wu, Kitty Yuechuan, Gillis, Joshua A., Moran, Steven L.

Mayo Clinic

Plastic & Reconstructive Surgery | December 22, 2021 | Volume: 149 | Issue: 1 | Pages: 108e-120e

10.1097/prs.0000000000008692 | PMID 34936631 Get It

Learning Objectives: After studying this article, the participant should be able to: 1. Understand the indications and management options for secondary flexor tendon reconstruction, including tenolysis, tendon grafting, and tendon transfers. 2. Understand the reconstructive options for pulley reconstruction. 3. Understand the options for management of isolated flexor digitorum profundus injuries. Summary: Despite current advances in flexor tendon repair, complications can still occur following surgery. This article presents the spectrum of treatment options for secondary flexor tendon reconstruction ranging from tenolysis to one- and two-stage tendon grafting, and tendon transfers. In addition, an overview of pulley reconstruction and the treatment of isolated flexor digitorum profundus injuries are discussed. A management algorithm for secondary flexor tendon reconstruction is provided.
Out-of-Pocket Costs Among Patients With a New Cancer Diagnosis Enrolled in High-Deductible Health Plans vs Traditional Insurance
Fu, Sue J. , Rose, Liam , Dawes, Aaron J. , Knowlton, Lisa Marie , Ruddy, Kathryn J. , Morris, Arden M.

Mayo Clinic

JAMA Network Open | December 22, 2021 | Volume: 4 | Issue: 12 | Pages: e2134282

10.1001/jamanetworkopen.2021.34282 | PMID 34935922 Get It

Abstract 1122‐000207: Mechanical Thrombectomy of the Fetal Posterior Cerebral Artery
Abdalkader, Mohamad , Sahoo, Anurag , Brinjikji, Waleed , Dabus, Guilherme , Raz, Eytan , Laiso, Antonio , Maud, Alberto , Galván‐Fernández, Jorge , Schüller, Miguel , Khandelwal, Priyank , Kiley, Nicole L. , Zaidat, Osama O. , Dmytriw, Adam A. , Dabus, Guilherme C. , Renieri, Leonardo , Martínez‐Galdámez, Mario , Al‐Mufti, Fawaz , Amuluru, Krishna , Fifi, Johanna T , Majidi, Shahram , Moore, Justin M. , Ortega-Gutierrez, Santiago , Hassan, Ameer E , Siegler, James E. , Nagel, Simon , Nguyen, Thanh N.

Mayo Clinic

Stroke: Vascular and Interventional Neurology | December 22, 2021 | Volume: 1 | Issue: S1 | Pages: No page available

10.1161/svin.01.suppl_1.000207 Get It

Introduction : Fetal posterior cerebral artery (FPCA) occlusion is a rare but potentially disabling cause of stroke. While endovascular treatment is established for acute large vessel occlusion (LVO) stroke, FPCA occlusions were excluded from acute ischemic stroke trials. We aim to report the feasibility, safety and outcome of mechanical thrombectomy (MT) in acute FPCA occlusions. Methods : We performed a multi‐center retrospective review of consecutive patients who underwent MT of acute FPCA occlusion. Primary FPCA occlusion was defined as an occlusion that was identified on the pre‐procedure CT angiogram or baseline angiogram whereas a secondary FPCA occlusion was defined as an occlusion that occurred secondary to embolization to a new territory after recanalization of a different LVO. Demographics, clinical presentation, imaging findings, endovascular treatment and outcome were reviewed. Results : There were twenty‐five patients with acute FPCA occlusion who underwent MT, distributed across 14 centers. Median NIHSS on presentation was 16. There were 76% (19/25) of patients who presented with primary FPCA occlusion and 24% (6/25) of patients who had a secondary FPCA occlusion. The configuration of the FPCA was full in 64% patients and partial or “fetal‐type” in 36% of patients. FPCA occlusion was missed on initial CTA in 21% of patients with primary FPCA occlusion (4/19). The site of occlusion was posterior communicating artery in 52%, P2 segment in 40% and P3 in 8% of patients. TICI 2b/3 reperfusion was achieved in 96% of FPCA patients. There were no intra‐procedural complications. At 90 days, 48% (12/25) were functionally independent as defined by mRS≤2. Conclusions : Endovascular treatment of acute FPCA occlusion is safe and technically feasible. A high index of suspicion is important to detect occlusion of the fetal posterior cerebral artery in patients presenting with anterior circulation stroke syndrome and patent anterior circulation.
Abstract 1122‐000165: Endovascular Intervention for a Thrombotic Adverse Event During Andexanet Alfa Infusion
Kayyali, Mohammad N , Dumitrașcu, Oana

Mayo Clinic

Stroke: Vascular and Interventional Neurology | December 22, 2021 | Volume: 1 | Issue: S1 | Pages: No page available

10.1161/svin.01.suppl_1.000165 Get It

Introduction : Andexanet alfa is the only specific reversal agent for factor Xa inhibitors and received FDA approval in 2018. Here we report an early infusion adverse event in a patient with acute intraventricular hemorrhage (IVH) that received Andexanet alfa, with an unfavorable outcome. Methods : A 73‐year‐old male presented to our emergency department (ED) after he developed sudden onset of severe headache without other associated neurological symptoms. An outpatient brain MRI showed IVH, that remained stable in size (2.4 cm3) on a follow‐up head CT performed in our ED. CT angiogram showed a 60% stenosis of the left supraclinoid internal carotid artery. The patient was taking apixaban 5 mg twice daily for atrial fibrillation (last dose 5.5 hours prior to presentation). Results : The anticoagulation was reversed with Andexanet alfa, 400 mg bolus given at 18:30, followed by 480 mg infusion over 2 hours started at 19:00 (12 hours from last apixaban dose). At 19:00, he developed left middle cerebral artery (MCA) ischemic stroke symptoms (global aphasia) that resolved with head‐of‐the‐bed flattening. CT perfusion demonstrated left ICA territory mismatch (342 ml) and 76 ml core. Shortly after CT perfusion, the patient developed a persistent complete left MCA stroke syndrome with NIH stroke scale (NIHSS) score 23. Decision was made to perform emergent cerebral angiogram which demonstrated a large, fresh thrombus in the left cervical ICA. Thrombectomy was successful with TICI score 2B. Patient’s neurological status initially improved. However, despite this intervention, patient developed a large territory infarct. As neurologic status remained poor, family withdrew care and patient died. Conclusions : ANNEXA‐A and ANNEXA‐R were parallel trials of Andexanet alfa for factor Xa inhibitor reversal that demonstrated a transient increase in prothrombotic factors post Andexanet alfa infusion. Neither of these phase 3 trials nor the previous phase 2 trials reported a clinical thrombotic event very early during the infusion. The ANNEXA‐4 trial (Phase 3) enrolled subjects with active major bleeding on a factor Xa inhibitor and 10% developed a thrombotic event during the 30‐day follow‐up period. 41% of the thrombotic complications were acute ischemic stroke (AIS), 35% (5 patients) experienced an AIS in the first six days post‐administration and the earliest reported thrombotic event occurred day 1 post infusion. Our case report illustrates an early cerebrovascular thrombotic event with dismal outcome despite timely and effective mechanical reperfusion therapy, which could be due to vessel re‐obstruction in setting of a hypercoagulable state. We aim to make vascular neurologists, neurointensivists and neurosurgeons aware of this possible occurrence when reversing patients with factor Xa‐related intracranial hemorrhages.
Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Merwe, Van der , Wanrooij, Roy L.J. van , Bronswijk, Michiel , Rimbaș, Mihai , Hucl, Tomáš , Kunda, Rastislav , Badaoui, Abdenor , Law, Ryan , Arcidiacono, Paolo Giorgio , Larghi, Alberto , Giovannini, Marc, Khashab, Mouen A. , Binmoeller, Kenneth F., Hooft, Jeanin E. van , van Wanrooij, Roy L J , Rimbas, Mihai , Kunda, Rastislav , Barthet, Marc , Perez-Miranda, Manuel , van Hooft, Jeanin E , Arcidiacono, Paolo Giorgio , Everett, Simon M , Lakhtakia, Sundeep , Pérez‐Miranda, Manuel

Mayo Clinic

Endoscopy | December 22, 2021 | Volume: 54 | Issue: 02 | Pages: 185-205

10.1055/a-1717-1391 | PMID 34937098 Get It

Main Recommendations 1 ESGE recommends the use of endoscopic ultrasound-guided biliary drainage (EUS-BD) over percutaneous transhepatic biliary drainage (PTBD) after failed endoscopic retrograde cholangiopancreatography (ERCP) in malignant distal biliary obstruction when local expertise is available. Strong recommendation, moderate quality evidence. 2 ESGE suggests EUS-BD with hepaticogastrostomy only for malignant inoperable hilar biliary obstruction with a dilated left hepatic duct when inadequately drained by ERCP and/or PTBD in high volume expert centers. Weak recommendation, moderate quality evidence. 3 ESGE recommends that EUS-guided pancreatic duct (PD) drainage should only be considered in symptomatic patients with an obstructed PD when retrograde endoscopic intervention fails or is not possible. Strong recommendation, low quality evidence. 4 ESGE recommends rendezvous EUS techniques over transmural PD drainage in patients with favorable anatomy owing to its lower rate of adverse events. Strong recommendation, low quality evidence. 5 ESGE recommends that, in patients at high surgical risk, EUS-guided gallbladder drainage (GBD) should be favored over percutaneous gallbladder drainage where both techniques are available, owing to the lower rates of adverse events and need for re-interventions in EUS-GBD. Strong recommendation, high quality of evidence. 6 ESGE recommends EUS-guided gastroenterostomy (EUS-GE), in an expert setting, for malignant gastric outlet obstruction, as an alternative to enteral stenting or surgery. Strong recommendation, low quality evidence. 7 ESGE recommends that EUS-GE may be considered in the management of afferent loop syndrome, especially in the setting of malignancy or in poor surgical candidates. Strong recommendation, low quality evidence. 8 ESGE suggests that endoscopic ultrasound-directed transgastric ERCP (EDGE) can be offered, in expert centers, to patients with a Roux-en-Y gastric bypass following multidisciplinary decision-making, with the aim of overcoming the invasiveness of laparoscopy-assisted ERCP and the limitations of enteroscopy-assisted ERCP. Weak recommendation, low quality evidence.
Leveling the Workload for Radiologists in Diagnostic Mammography: Application of Lean Principles and Heijunka
Conners, Amy Lynn , Clark, Sean E, Brandt, Kathleen R. , Hunt, Katie N. , Chida, Linda, Tibor, Laura C. , Ruter, Royce, Khanani, Sadia, Conners, Amy L , Chida, Linda M, Ruter, Royce L, Khanani, Sadia A, Clark, Sean E.

Mayo Clinic

Journal of Breast Imaging | December 22, 2021 | Volume: 4 | Issue: 1 | Pages: 61-69

10.1093/jbi/wbab090 | PMID 38422417 Get It

Abstract To facilitate the delivery of accurate and timely care to patients in complex environments, process improvement methodologies such as Lean can be very effective. Lean is a quality improvement methodology that seeks to add value for patients and employees by continuously improving processes and eliminating waste. At our institution, Lean principles were applied to improve efficiency and minimize waste in the diagnostic breast imaging reading room. This paper describes how we applied Lean principles, including plan-do-study-act testing, level-loading (heijunka), and visual management, to level the workload of the diagnostic radiologists in our practice. Implementation of these principles to improve the diagnostic workflow in breast imaging is described along with examples from our practice, including challenges and future opportunities.
Impact of blood pressure on coronary perfusion and valvular hemodynamics after aortic valve replacement
Vogl, Brennan , Darestani, Yousef Mohammadi , Lilly, Scott , Thourani, Vinod H. , Hatoum, Hoda , Alkhouli, Mohamad A, Hatoum, Hoda , Alkhouli, Mohamad , Lindman, Brian R.

Mayo Clinic

Catheterization and Cardiovascular Interventions | December 22, 2021 | Volume: 99 | Issue: 4 | Pages: 1214-1224

10.1002/ccd.30052 | PMID 34936723 Get It

Abstract Objective Our objective was to evaluate the impact of various blood pressures (BPs) on coronary perfusion and valvular hemodynamics following aortic valve replacement (AVR). Background Lower systolic and diastolic (SBP/DBP) pressures from the recommended optimal target range of SBP < 120–130 mmHg and DBP < 80 mmHg after AVR have been independently associated with increased cardiovascular and all‐cause mortality. Methods The hemodynamic assessment of a 26 mm SAPIEN 3 transcatheter aortic valve (TAV), 29 mm Evolut R TAV, and 25 mm Magna Ease surgical aortic valve (SAV) was performed in a pulsed left heart simulator with varying SBP, DBP, and heart rate (HR) conditions (60 and 120 bpm) at 5 L/min cardiac output (CO). Average coronary flow (CF), effective orifice areas (EOAs), and valvulo‐arterial impedance (Zva) were calculated. Results At HR of 60 bpm, at SBP < 120 mmHg and DBP < 60 mmHg, CF decreased below the physiological lower limit with several different valves. Zva and EOA were found to increase and decrease respectively with increasing SBP and DBP. The same results were found with an HR of 120 bpm. The trends of CF variation with BP were similar in all valves however the drop below the lower physiological CF limit was valve dependent. Conclusion In a controlled in vitro system, with different aortic valve prostheses in place, CF decreased below the physiologic minimum when SBP and DBP were in the range targeted by blood pressure guidelines. Combined with recent observations from patients treated with AVR, these findings underscore the need for additional studies to identify the optimal BP in patients treated with AVR for AS.
Portal Message Language Use Prior to Suicide, Suicide Attempts, and Hospitalization for Depression
Duvall, Michelle J., Miller, Nathaniel E. , North, Frederick , Leasure, William B. , Pecina, Jennifer L. , Duvall, Michelle , Miller, Nathaniel E , Pecina, Jennifer

Mayo Clinic

Telemedicine and e-Health | December 22, 2021 | Volume: 28 | Issue: 8 | Pages: 1143-1150

10.1089/tmj.2021.0318 | PMID 34936819 Get It